Rights and permissions
About this article
Cite this article
Rizatriptan worth it in Canada for moderate-to-severe migraine. Inpharma Wkly. 1502, 4 (2005). https://doi.org/10.2165/00128413-200515020-00006
Published:
Issue Date:
DOI: https://doi.org/10.2165/00128413-200515020-00006